Clobazam and Phentermine and topiramate interaction

Clobazam and Phentermine and topiramate: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Clobazam (SYMPAZAN) label · effective 2025-12-01

Moderate

Risk may be increased with concomitant use of other CNS depressants ( 5.4 , 5.5 )

Warnings and precautionsby drug classView label on DailyMed
Moderate

Prescribe the lowest effective dosage; avoid or minimize concomitant use of CNS depressants and other substances associated with abuse, misuse, and addiction (e.g., opioid analgesics, stimulants); and advise patients on the proper disposal of unused drug.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Prescribers should monitor patients for somnolence and sedation, particularly with concomitant use of other central nervous system depressants.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Strong or Moderate CYP2C19 Inhibitors: Dosage adjustment of SYMPAZAN ® may be necessary ( 7.4 )

Drug interactionsby drug classView label on DailyMed
Moderate

Therefore, caution patients or their caregivers against simultaneous use with other CNS depressant drugs or alcohol, and caution that the effects of other CNS depressant drugs or alcohol may be potentiated [see Warnings and Precautions (5.4) ].

Drug interactionsby drug classView label on DailyMed

From the Phentermine and topiramate label · effective 2026-05-18

Moderate

The concomitant use of alcohol or central nervous system (CNS) depressant drugs with phentermine and topiramate extended-release capsules may potentiate CNS depression or other centrally mediated effects of these agents, such as dizziness, cognitive adverse reactions, drowsiness, light-headedness, impaired coordination, and somnolence.

Warnings and precautionsby drug classView label on DailyMed
Moderate

CNS Depressants Including Alcohol Clinical Impact The concomitant use of alcohol or CNS depressant drugs (e.g., barbiturates, benzodiazepines, and sleep medications) with phentermine or topiramate may potentiate CNS depression such as dizziness or cognitive adverse reactions, or other centrally mediated effects of these agents.

Drug interactionsby drug classView label on DailyMed
Moderate

CNS Depressants Including Alcohol : May potentiate CNS depressant effects.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.